Difficulty: Medium
Average Score: 87%
Practice
Which one of the following drugs has no effect on prothrombin but increases the likelihood of bleeding in patients who are also taking warfarin?
Correct answer
C
Rationale
The correct answer is C) Naproxen. Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that interferes with platelet function, leading to an increased risk of bleeding when used concomitantly with warfarin. While Naproxen does not directly affect prothrombin levels, its antiplatelet effects can potentiate the anticoagulant effects of warfarin, thus increasing the likelihood of bleeding in patients.
A) Carbamazepine is an anticonvulsant drug and does not directly impact bleeding risk in patients on warfarin therapy.
B) Cholestyramine is a bile acid sequestrant used to lower cholesterol and has no known interactions with warfarin in terms of increasing bleeding risk.
D) Rifampin is an antibiotic that induces hepatic enzymes and can reduce the effectiveness of warfarin but does not directly increase the risk of bleeding in the presence of warfarin.
Educational Context: Understanding the interactions between drugs used for gastrointestinal disorders and anticoagulants is crucial for healthcare professionals to ensure patient safety and optimal therapeutic outcomes. This knowledge helps in making informed decisions regarding drug selection and monitoring to prevent adverse events such as bleeding complications.
A) Carbamazepine is an anticonvulsant drug and does not directly impact bleeding risk in patients on warfarin therapy.
B) Cholestyramine is a bile acid sequestrant used to lower cholesterol and has no known interactions with warfarin in terms of increasing bleeding risk.
D) Rifampin is an antibiotic that induces hepatic enzymes and can reduce the effectiveness of warfarin but does not directly increase the risk of bleeding in the presence of warfarin.
Educational Context: Understanding the interactions between drugs used for gastrointestinal disorders and anticoagulants is crucial for healthcare professionals to ensure patient safety and optimal therapeutic outcomes. This knowledge helps in making informed decisions regarding drug selection and monitoring to prevent adverse events such as bleeding complications.